JPRN-UMIN000042709
Completed
未知
Study of the involvement of the gut microbiota in the pathophysiology and treatment effect of patients with unresectable hepatocellular carcinoma. - Study of the involvement of the gut microbiota in the pathophysiology and treatment effect of patients with unresectable hepatocellular carcinoma.
ConditionsHepatocellular carcinoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hepatocellular carcinoma
- Sponsor
- Kurume university
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •A) Patients with unresectable advanced hepatocellular carcinoma. 1\. Patients with decreased hepatic reserve (Child\-Pugh class C). 2\. Patients with intractable ascites. 3\. Patients judged by the principal investigator and the research coordinator to be inappropriate as research subjects. B) Patients with liver cirrhosis. 1\. Patients with decreased hepatic reserve (Child\-Pugh class C). 2\. Patients with intractable ascites. 3\. Patients judged by the principal investigator and the research coordinator to be inappropriate as research subjects. 4\. Patients who have been treated with antibacterial drugs due to the appearance of hepatic encephalopathy. C) Healthy person. 1\. Those who are pregnant or breastfeeding, or those who are judged by the principal investigator and the research coordinator to be inappropriate as research subjects.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The influence of the intestinal microbiome on the development of postoperative complications after elective colon surgery - a prospective cohort studyK91.83T79.3Post-traumatic wound infection, not elsewhere classifiedDRKS00014059niversitätsklinikum FreiburgInstitut für Umweltmedizin und KrankenhaushygieneUni-Zentrum Naturheilkunde127
Recruiting
Not Applicable
Investigation of the gut microbiome in patients with head and neck cancer (HNSCC) and analysis of the prognostic potential of response and tolerability of PD-1, PDL-1 immune checkpoint inhibitors in head and neck cancerhead and neck carcinomaDRKS00032481ehrstuhl für Hals-Nasen-Ohrenheilkunde Universität Witten/Herdecke50
Completed
Not Applicable
Alterations of the gut microbiome in patients with IBS in correlation to illness anxiety and symptom severityK58F45.32Irritable bowel syndromeDRKS00033141niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik70
Completed
Not Applicable
The effect of gut microbiota on the response to neoadjuvant DCF therapy for locally advanced esophageal cancer: A single center prospective studyesophageal cancerJPRN-UMIN000035732Department of gastrointestinal Surgery, Graduate School of Medicine, The university of Tokyo50
Completed
Not Applicable
The analysis of influences on the gut microbiota, the glycometabolism and the peritoneal permeability by the induction of dialysis and the peritonitis prevalence in peritoneal dialysis patients.end stage renal failureJPRN-UMIN000014814Keio university school of medicine20